221 related articles for article (PubMed ID: 30608261)
21. Glioma-Associated Oncogene-1 Expression in Basal Cell Carcinoma and Its Histologic Mimics.
Gradecki SE; Eid MV; Pramoonjago P; Wick MR
Am J Dermatopathol; 2021 Sep; 43(9):637-641. PubMed ID: 33264133
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous sebaceous neoplasms.
Rulon DB; Helwig EB
Cancer; 1974 Jan; 33(1):82-102. PubMed ID: 4129561
[No Abstract] [Full Text] [Related]
23. Twenty-Eight Cases of Extraocular Sebaceous Carcinoma: A Correlative Clinicopathological and Immunohistochemical Analysis of Extraocular Sebaceous Carcinomas and Benign Sebaceous Gland Tumors.
Boecker W; Reusch M; Mielke V; Reusch U; Hallermann C; Loening T; Tiemann M; Buchwalow I
Am J Dermatopathol; 2021 Feb; 43(2):93-102. PubMed ID: 32568835
[TBL] [Abstract][Full Text] [Related]
24. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma.
Valente AL; Tull J; Zhang S
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
26. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases.
Ostler DA; Prieto VG; Reed JA; Deavers MT; Lazar AJ; Ivan D
Mod Pathol; 2010 Apr; 23(4):567-73. PubMed ID: 20118912
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.
Foo WC; Cruise MW; Wick MR; Hornick JL
Am J Clin Pathol; 2011 Jun; 135(6):839-44. PubMed ID: 21571956
[TBL] [Abstract][Full Text] [Related]
28. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
Mittal R; Araujo I; Czanner G; Coupland SE
Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
[TBL] [Abstract][Full Text] [Related]
29. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
30. Sebaceous neoplasms in Muir-Torre syndrome.
Misago N; Narisawa Y
Am J Dermatopathol; 2000 Apr; 22(2):155-61. PubMed ID: 10770437
[TBL] [Abstract][Full Text] [Related]
31. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
32. Sebaceoma and related neoplasms with sebaceous differentiation: a clinicopathologic study of 30 cases.
Misago N; Mihara I; Ansai S; Narisawa Y
Am J Dermatopathol; 2002 Aug; 24(4):294-304. PubMed ID: 12142607
[TBL] [Abstract][Full Text] [Related]
33. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
Kosemehmetoglu K; Vrana JA; Folpe AL
Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
[TBL] [Abstract][Full Text] [Related]
34. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
Mihailovici MS; Teleman S; Ungureanu C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
[TBL] [Abstract][Full Text] [Related]
35. Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.
Sasaki K; Sugai T; Ishida K; Osakabe M; Amano H; Kimura H; Sakuraba M; Kashiwa K; Kobayashi S
Hum Pathol; 2018 Sep; 79():1-8. PubMed ID: 29555579
[TBL] [Abstract][Full Text] [Related]
36. Distinction of benign sebaceous proliferations from sebaceous carcinomas by immunohistochemistry.
Cabral ES; Auerbach A; Killian JK; Barrett TL; Cassarino DS
Am J Dermatopathol; 2006 Dec; 28(6):465-71. PubMed ID: 17122489
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin.
Tellechea O; Reis JP; Domingues JC; Baptista AP
Am J Dermatopathol; 1993 Oct; 15(5):452-5. PubMed ID: 8238781
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
Sinard JH
Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
[TBL] [Abstract][Full Text] [Related]
40. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin.
East E; Fullen DR; Arps D; Patel RM; Palanisamy N; Carskadon S; Harms PW
Am J Dermatopathol; 2016 Oct; 38(10):744-50. PubMed ID: 27043336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
